Clinical Trials Directory

Trials / Completed

CompletedNCT02067286

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV

Status
Completed
Phase
Study type
Observational
Enrollment
1,642 (actual)
Sponsor
IQuum, Inc. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2014-02-20
Last updated
2016-08-31

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02067286. Inclusion in this directory is not an endorsement.